Status:
COMPLETED
Mobile Application-delivered Resistance Program for Children and Adolescents With Type 1 Diabetes (Diactive-1)
Lead Sponsor:
Fundacion Miguel Servet
Collaborating Sponsors:
Complejo Hospitalario de Navarra
Universidad Pública de Navarra
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
8-18 years
Phase:
NA
Brief Summary
This project involves a two-arm randomized controlled trial (RCT) designed to assess the feasibility, acceptability, and preliminary efficacy of a mobile application aimed at prescribing resistance tr...
Detailed Description
The primary objective of this study is to evaluate the effectiveness of the Diactive-1 mobile application, which offers personalized resistance training, in reducing daily insulin requirements among c...
Eligibility Criteria
Inclusion
- Aged 8-18 years old
- At least 6 months post-diagnosis for type 1 diabetes
- Ability to complete measures and intervention program in Spanish
- Access to broadband or cellular internet
- Patients who signed the informed consent form prior to participation; for minors, a legal representative must provide consent and sign the informed consent form.
Exclusion
- Any comorbidity limiting the capacity to participate in physical activity or inadequate understanding of the Spanish language.
- Participants will be excluded if they don't have access to the internet, lack a smartphone or tablet, or are unable to use the application.
Key Trial Info
Start Date :
August 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT06048757
Start Date
August 20 2023
End Date
October 1 2024
Last Update
December 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundación Miguel Servet/ Navarrabiomed
Pamplona, Navarre, Spain, 31008
2
Paediatric Endocrinology Unit at Hospital Universitario de Navarra
Pamplona, Navarre, Spain, 31008